tiprankstipranks
Trending News
More News >
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
Advertisement

Daito Pharmaceutical Co., Ltd. (4577) Financial Statements

Compare
0 Followers

Daito Pharmaceutical Co., Ltd. Financial Overview

Daito Pharmaceutical Co., Ltd.'s market cap is currently ¥36.89B. The company's EPS TTM is ¥22.875; its P/E ratio is 19.55; and it has a dividend yield of 4.28%. Daito Pharmaceutical Co., Ltd. is scheduled to report earnings on July 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 50.64B¥ 46.90B¥ 45.10B¥ 43.46B¥ 48.71B
Gross Profit¥ 8.64B¥ 9.84B¥ 10.33B¥ 11.46B¥ 10.79B
Operating Income¥ 2.62B¥ 3.89B¥ 5.21B¥ 6.55B¥ 5.91B
EBITDA¥ 7.41B¥ 7.92B¥ 8.96B¥ 9.88B¥ 9.04B
Net Income¥ 1.91B¥ 3.29B¥ 3.60B¥ 4.67B¥ 4.25B
Balance Sheet
Cash & Short-Term Investments¥ 2.21B¥ 2.73B¥ 3.61B¥ 4.38B¥ 3.37B
Total Assets¥ 78.00B¥ 77.71B¥ 70.55B¥ 64.94B¥ 57.74B
Total Debt¥ 11.88B¥ 8.72B¥ 4.96B¥ 3.45B¥ 3.39B
Net Debt¥ 9.68B¥ 5.99B¥ 1.35B¥ -934.00M¥ 21.09M
Total Liabilities¥ 25.93B¥ 25.44B¥ 19.58B¥ 17.27B¥ 15.82B
Stockholders' Equity¥ 52.00B¥ 52.07B¥ 50.67B¥ 47.30B¥ 41.62B
Cash Flow
Free Cash Flow¥ -957.00M¥ -1.09B¥ -1.40B¥ -363.00M¥ -1.17B
Operating Cash Flow¥ 5.90B¥ 5.18B¥ 4.16B¥ 4.37B¥ 5.18B
Investing Cash Flow¥ -7.37B¥ -5.93B¥ -5.57B¥ -4.40B¥ -6.32B
Financing Cash Flow¥ 1.00B¥ -183.00M¥ 616.00M¥ 989.00M¥ 1.42B
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History

Daito Pharmaceutical Co., Ltd. Debt to Assets

Daito Pharmaceutical Co., Ltd. Cash Flow

Daito Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis